BioDelivery Sciences Inte...

NASDAQ: BDSI · Real-Time Price · USD
5.59
-0.00 (-0.09%)
At close: Mar 22, 2022, 9:00 PM

BioDelivery Sciences International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
166.7M
Cost of Revenue
23.37M
Gross Profit
143.33M
Operating Income
37.12M
Interest Income
n/a
Pretax Income
29.62M
Net Income
84.86M
Selling & General & Admin
106.21M
Research & Development
n/a
Other Expenses
n/a
Operating Expenses
106.21M
Interest Expense
7.5M
Selling & Marketing Expenses
n/a
Cost & Expenses
129.58M
Income Tax Expense
-55.24M
Shares Outstanding (Basic)
103.29M
Shares Outstanding (Diluted)
103.29M
EPS (Basic)
0.82
EPS (Diluted)
0.82
EBITDA
44.54M
EBIT
37.12M
Depreciation & Amortization
7.42M